- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Ritholtz Wealth Management CEO Josh Brown explained why he likes Bristol-Myers best in the pharma space.
Here are Friday's top research calls, including upgrades for AK Steel, ServiceNow, Qualcomm and Twitter, and downgrades for McKesson, Mead Johnson and GNC.
Let me give you the unassailable themes.
The consolidation patterns on these charts project higher prices.